Journal article icon

Journal article : Review

Mapping Causal Biology: Mendelian Randomization in the Era of Big Data

Abstract:
Mendelian randomization (MR) is a method that utilizes genetic variants as instrumental variables to determine causal relationships between exposures and outcomes, thereby mitigating confounding bias and reverse causality inherent in observational studies. Rooted in Mendel's laws of inheritance, MR has undergone rapid development since Katan first introduced the concept in 1986, followed by the formalization of its methodology by George Davey Smith and Ebrahim in 2003. This review comprehensively summarizes the theoretical foundations, methodological innovations, and expanding applications of MR. This review discusses the three core assumptions underpinning MR methodologies—relevance, independence, and exclusion restriction—and examines advanced methodological extensions, two‐sample MR, multivariable MR, bidirectional MR, non‐linear MR, cis‐MR, mediation MR, multi‐population MR, and cluster MR. It further provides an overview of key commonly used R packages, databases, and analytical workflows that facilitate the implementation of MR. Application domains spanning gene–environment interactions research, public health, complex diseases, drug target validation, and integration with other cutting‐edge technologies are highlighted through representative case studies demonstrating their translational potential. Lastly, we critically assess methodological limitations, including weak instrument bias, horizontal pleiotropy, population stratification, data quality heterogeneity, lack of benchmark validation and comparison across MR methods, as well as selection and collider bias, while proposing future directions for improving robustness and expanding the applicability of MR through integration with multi‐omics and cross‐ancestry analyses. Overall, MR serves as a cornerstone in modern causal inference research, bridging genetics, epidemiology, and precision medicine to advance our understanding of disease etiology and therapeutic innovation.
Publication status:
Published
Peer review status:
Peer reviewed

Actions

Access Document

Files:
Publisher copy:
10.1002/mdr2.70074

Authors

More by this author
Institution:
University of Oxford
Role:
Author
ORCID:
0000-0003-4417-0864
More by this author
Role:
Author
ORCID:
0009-0008-1163-0135


Publisher:
Wiley
Journal:
Med Research More from this journal
Article number:
mdr2.70074
Publication date:
2026-06-26
Acceptance date:
2026-06-01
DOI:
EISSN:
2998-4971
ISSN:
2998-4963


Language:
English
Keywords:
Subtype:
Review
Source identifiers:
4273518
Deposit date:
2026-06-27
ARK identifier:
This ORA record was generated from metadata provided by an external service. It has not been edited by the ORA Team.

Terms of use


Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP